Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

Hot on Facebook
Uproar After NC State Agent 'Fixes' Girl's Lunch Preschooler has to eat chicken nuggets instead of mom's meal »

New Drug Battles Liver Cancer

Nexavar, already approved for kidney cancer, shows promise in liver patients

By Sarah Seltzer,  Newser User

Posted Jun 4, 2007 7:37 AM CDT

(Newser) – An impressive clinical trial has produced what could be the first effective drug treatment for liver cancer, the New York Times reports. Nexavar, which blocks both the blood supply to the tumor and proteins that spur tumor growth, extended the lives of patients in the trial by almost three months, or 44%

"We did not have anything for these patients," said one of the principal investigators  in the trial. "Now we have an effective drug that prolongs survival." The drug, also known as sorafenib, is already approved to treat kidney cancer, so it can be prescribed "off label" to liver patients. Liver cancer is one of the most common, and deadliest, forms of the disease.

US NEWS LIVERCANCER 2 MW
US NEWS LIVERCANCER 2 MW   (KRT Photos)
US NEWS LIVERCANCER 1 MW
US NEWS LIVERCANCER 1 MW   (KRT Photos)
« Prev« Prev | Next »Next » Slideshow
To report an error on this story, notify our editors.
A snapshot of the day's best news stories.
 
COMMENTS
Be the first to comment on this story.

More Newser Stories

Promising 'Trojan Horse' Cells Kills Animal Cancer

New Cancer Strategy: Don't Cure It, Manage It

Are Your Meds Working? Gene Tests Could Tell

New Drug Protects Body From Radiation

Hospitals Seduced by 'Nuclear Arms Race' vs. Cancer


NEWS FROM OUR PARTNERS
Other Sites We Like:   24/7 Wall St.   |   Betty Confidential   |   BuzzFeed   |   Cracked   |   Fark   |   Timelines   |   The Frisky   |   Geek Sugar   |   NewsOne